LND vs. AVO, FDP, TED, MET1, EMH, ATM, ZNWD, FAR, ARS, and KAV
Should you be buying Landore Resources stock or one of its competitors? The main competitors of Landore Resources include Advanced Oncotherapy (AVO), FD Technologies (FDP), Ted Baker (TED), Metals One (MET1), European Metals (EMH), Andrada Mining (ATM), Zinnwald Lithium (ZNWD), Ferro-Alloy Resources (FAR), Asiamet Resources (ARS), and Kavango Resources (KAV).
Landore Resources vs.
Advanced Oncotherapy (LON:AVO) and Landore Resources (LON:LND) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, valuation, risk, institutional ownership, profitability, community ranking, media sentiment and dividends.
Landore Resources is trading at a lower price-to-earnings ratio than Advanced Oncotherapy, indicating that it is currently the more affordable of the two stocks.
Advanced Oncotherapy's return on equity of -67.34% beat Landore Resources' return on equity.
Advanced Oncotherapy has a beta of 0.06, indicating that its share price is 94% less volatile than the S&P 500. Comparatively, Landore Resources has a beta of -0.15, indicating that its share price is 115% less volatile than the S&P 500.
In the previous week, Landore Resources had 1 more articles in the media than Advanced Oncotherapy. MarketBeat recorded 1 mentions for Landore Resources and 0 mentions for Advanced Oncotherapy. Advanced Oncotherapy's average media sentiment score of 0.00 beat Landore Resources' score of -0.35 indicating that Advanced Oncotherapy is being referred to more favorably in the media.
17.8% of Advanced Oncotherapy shares are owned by institutional investors. Comparatively, 3.2% of Landore Resources shares are owned by institutional investors. 47.5% of Advanced Oncotherapy shares are owned by insiders. Comparatively, 39.6% of Landore Resources shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Advanced Oncotherapy received 122 more outperform votes than Landore Resources when rated by MarketBeat users. Likewise, 60.97% of users gave Advanced Oncotherapy an outperform vote while only 57.76% of users gave Landore Resources an outperform vote.
Summary
Advanced Oncotherapy beats Landore Resources on 9 of the 12 factors compared between the two stocks.
Get Landore Resources News Delivered to You Automatically
Sign up to receive the latest news and ratings for LND and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Landore Resources Competitors List
Related Companies and Tools
This page (LON:LND) was last updated on 5/1/2025 by MarketBeat.com Staff
Buy LND Stock Free LND Stock Alerts